MedPath
FDA Approval

MOXIFLOXACIN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Direct Rx
DUNS: 079254320
Effective Date
February 7, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Direct Rx

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Direct Rx

Direct Rx

Direct Rx

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MOXIFLOXACIN

Product Details

NDC Product Code
72189-321
Application Number
ANDA202867
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
February 7, 2022
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
BORIC ACIDInactive
Code: R57ZHV85D4Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: B8956S8609Class: ACTIMQuantity: 5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath